دورية أكاديمية
أعرض في EDS

Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy

التفاصيل البيبلوغرافية
العنوان: Real-World Clinical Outcomes in Asthmatic Patients Switched from Omalizumab to Anti-Interleukin-5 Therapy
المؤلفون: O'Reilly E, Casey D, Ibrahim H, McGrath A, McHugh T, Vairamani P, Murphy J, Plant B, Murphy DM
المصدر: Journal of Asthma and Allergy, Vol Volume 15, Pp 935-937 (2022)
بيانات النشر: Dove Medical Press, 2022.
سنة النشر: 2022
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: asthma, anti-interleukin-5, omalizumab, refractory asthma, type 2 inflammation, Immunologic diseases. Allergy, RC581-607
الوصف: Emily O’Reilly,1 Deborah Casey,1 Hisham Ibrahim,1 Alice McGrath,1 Tomás McHugh,1 Punitha Vairamani,1 Jill Murphy,1 Barry Plant,1,2 Desmond M Murphy1,2 1Department of Respiratory Medicine, Cork University Hospital, Cork, Ireland; 2Health Research Board Clinical Research Facility, University College Cork, Cork, IrelandCorrespondence: Desmond M Murphy, Department of Respiratory Medicine, Cork University Hospital, Wilton, Cork, Ireland, Email desmond.murphy@hse.ie
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1178-6965
Relation: https://www.dovepress.com/real-world-clinical-outcomes-in-asthmatic-patients-switched-from-omali-peer-reviewed-fulltext-article-JAA; https://doaj.org/toc/1178-6965
URL الوصول: https://doaj.org/article/42f15392b5604f84af27c442337b51c8
رقم الأكسشن: edsdoj.42f15392b5604f84af27c442337b51c8
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:11786965